Is Puma Biotechnology, Inc. (PBYI) halal? Doubtful. Based on AAOIFI screening, Puma Biotechnology, Inc. passes the business activity screen but has financial ratios approaching AAOIFI limits with a compliance score of 62/100 (Grade: B).
PBYI — Is Puma Biotechnology, Inc. Halal?
DoubtfulPuma Biotechnology, Inc.
$6.98
-1.97%
About Puma Biotechnology, Inc.
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer; PB272 (neratinib, oral) for HER2 mutation-positive solid tumors. It has a license agreement with Pfizer, Inc.; and sub-license agreement with Specialised Therapeutics Asia Pte Ltd., CANbridge BIOMED Limited, Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. The company was founded in 2010 and is headquartered in Los Angeles, California.
Sector: Healthcare · Industry: Biotechnology
Why This Stock Is Doubtful
- Interest-bearing deposits are 27.5% of market cap — only 2.5 points below the 30% limit
Stocks are marked Doubtful when financial ratios pass but approach AAOIFI thresholds. Consider consulting a qualified scholar for a definitive ruling.
Shariah Compliance Status
Based on AAOIFI screening standards
Acceptable
Acceptable but room for improvement
Business Activity Screen
PassedChecks if the business is involved in prohibited activities (alcohol, gambling, pork, conventional banking, etc.)
Financial Ratio Screen
PassedFinancial ratios must be below AAOIFI thresholds
Compliance History
Doubtfulnow
since Jun 2026
Not Halal
until the change above
Tracked since Jun 2026. Updates automatically on each re-screen.
Purify Your PBYI Dividends
2.4% non-compliant incomePBYI has 2.4% prohibited income. Calculate exactly how much of your dividends to donate.
Financial Overview
Market Cap
355.3M
Price
$6.98
Sector
Healthcare
Industry
Biotechnology
More Healthcare Stocks
Track PBYI and 10,000+ stocks with AI insights
Create your free account to unlock AI-powered compliance analysis, track your portfolio, calculate purification, and get unlimited AAOIFI screening.
Disclaimer: This screening is for informational purposes only and does not constitute financial, legal, or religious advice. Compliance is evaluated using AAOIFI financial standards (debt, deposits, and prohibited income ratios) and publicly available data. Ethical, political, social, or environmental considerations are outside the scope of this screening. Individual scholars and methodologies may differ. Always consult a qualified Islamic finance advisor before making investment decisions.